N-able Inc Ordinary Shares NABL 深 滬
等待開盤 11-26 09:30:00 美东时间
7.35
+0.150
+2.08%
華盛通- 最 高7.385
- 今 開7.24
- 成交量 74.65万股
- 最 低 7.185
- 昨 收 7.20
- 總市值 13.74亿
- 52周最高 10.495
- 市盈率 靜 44.74
- 換手率 0.40%
- 52周最低 6.07
- 委 比 -56.74%
- 總股本 1.87亿
- 歷史最高 15.85
- 量 比 0.83
- 振 幅 2.78%
- 歷史最低 6.07
- 每 手 1
- 風險率 1.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多N-able Empowers DoD Contractors with New Cybersecurity Tools for Stronger Business Resilience
N-able, Inc. (NYSE:NABL), a global software company delivering an end-to-end cyber resilience platform, today announced the public preview of a version of its N-able N-central unified endpoint management (UEM) solution
11-18 19:09
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
N-able shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 sales guidance above estimates. Also, the company raised its FY25 sales guidance above estimates.
N-able shares are trading higher after the company reported better-than-expecte...
11-06 22:24
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
N-Able shares are trading higher after the company reported better-than-expected Q2 financial results, issued Q3 sales guidance above estimates, and raised its FY25 sales guidance above estimates.
N-Able shares are trading higher after the company reported better-than-expecte...
08-07 21:12
N-able Sees Q3 Sales $127.000M-$128.000M vs $125.138M Est
N-able (NYSE:NABL) sees Q3 sales of $127.000 million-$128.000 million vs $125.138 million analyst estimate.
08-07 19:03
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
A Look Into N-able Inc's Price Over Earnings
Looking into the current session, N-able Inc. (NYSE:NABL) shares are trading at...
07-17 05:00
